Blood Lipid Responses to Diet
Launched by UNIVERSITY OF OXFORD · Jul 31, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different amounts of carbohydrates and fats in our diets affect blood lipid levels (fats in the blood) and liver function in healthy adults. The researchers want to understand the best dietary balance to help lower the risk of heart disease and other metabolic conditions. They will also look at how a person's genes may influence how their body responds to these dietary changes.
To participate in this study, individuals must be between 18 and 65 years old, have a stable weight for the last three months, and have a body mass index (BMI) within a specific range. Participants should not have any medical conditions or take medications that could affect metabolism. Those who join can expect to follow a specific diet and undergo testing to measure their blood lipid levels and liver health. It's important to note that people with certain health issues, significant weight changes, or other specific criteria will not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the study.
- • Male or Female, aged ≥18 to ≤65 years
- • Body mass index (BMI) ≥19 to ≤35 kg/m2
- • No medical condition or relevant drug therapy that is known to affect the liver, adipose tissue, or cardiac metabolism.
- • Weight stable for the previous 3 months
- Exclusion Criteria:
- • Aged \<18 or \>65 years
- • BMI \<19 or \>35 kg/m2
- • A blood haemoglobin \<135 mg/dL for men and \<120 mg/dL for women
- • Donated (or lost) ≥250 mL of blood in the previous two months
- • On a weight loss diet or decreased their body weight by \>5% in the previous 3 months
- • Currently adhering to or have consumed in the previous 3 months a diet with a notably altered macro-nutrient content (e.g. high-fat - low-carbohydrate diet)
- • Have increased their body weight by \>5% in the previous 3 months
- • Any metabolic condition or relevant drug therapy
- • Current smoker
- • History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women)
- • History of albumin allergy.
- • Pregnant or nursing mothers
- • History of severe claustrophobia
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, , United Kingdom
Oxford, , United Kingdom
Patients applied
Trial Officials
Leane Hodson
Principal Investigator
University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported